Featuring one-on-one interviews conducted by Dr Neil Love, this series bridges the gap between research and patient care by providing medical oncologists, hematologists and hematology/oncology fellows ongoing access to the perspectives and opinions of national and international research leaders with an expertise in thoracic oncology.
Publishes | Twice monthly | Episodes | 359 | Founded | 19 years ago |
---|---|---|---|---|---|
Number of Listeners | Categories | Health & FitnessMedicineScience |
Dr Jacob Sands from Dana-Farber Cancer Institute in Boston, Massachusetts, discusses recent developments with TROP2-directed antibody-drug conjugates in the management of lung cancer.
CME information and select publications here.
Dr Stephen V Liu from Georgetown University Hospital in Washington, DC and Dr Charles Rudin from Memorial Sloan Kettering Cancer Center in New York discuss the role of approved and novel investigational therapies for patients with limited-stage and e... more
Dr Jacob Sands from Dana-Farber Cancer Institute in Boston, Massachusetts, discusses recent developments with TROP2-directed antibody-drug conjugates in the management of non-small cell lung cancer.
CME information and select publications here.
Dr Benjamin Levy from Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial in Washington, DC, discusses important efficacy and safety data from 2024 related to the use of approved and investigational therapies for localized and advanced non-s... more
People also subscribe to these shows.
Third year medicine resident applying to Heme onc fellowship. I am interested in lung cancer and this podcast inspires critical thinking about patient management and provokes thought about the lung cancer literature. Uniquely has fantastic interviews with experts in the field. A great listen. I recommend this to anyone interested in oncology and interested in improving their knowledge of lung cancer management.
Hier ben ik heel blij mee.
Ik wou dat zoiets in het Nederlands bestond.
Key themes from listener reviews, highlighting what works and what could be improved about the show.
Recent interactions between the hosts and their guests.
Listeners, social reach, demographics and more for this podcast.
Listeners per Episode | |
---|---|
Gender Skew | |
Location | |
Interests | |
Professions | |
Age Range | |
Household Income | |
Social Media Reach |
Content revolves around the latest advancements and treatment strategies in lung cancer, making it essential for oncology professionals at various levels. Frequent discussions with leading experts highlight complex cases and emerging therapies, providing valuable insights into personalized medicine, targeted therapies, immunotherapy, and overall patient management. The series aims to enhance critical thinking regarding treatment options for both small cell and non-small cell lung cancer, addressing both recent developments and practical applications in clinical settings. Unique aspects include an emphasis on expert interviews that connect current research findings with real-world patient care challenges, aiming to keep healthcare profession... more
Rephonic provides a wide range of podcast stats for Lung Cancer Update. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to Lung Cancer Update and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.
Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for Lung Cancer Update, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.
Rephonic provides comprehensive predictive audience data for Lung Cancer Update, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.
To see how many followers or subscribers Lung Cancer Update has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.
These podcasts share a similar audience with Lung Cancer Update:
1. Gastrointestinal Cancer Update
2. Two Onc Docs
3. Breast Cancer Update
4. Oncology Today with Dr Neil Love
5. Research To Practice | Oncology Videos
Lung Cancer Update launched 19 years ago and published 359 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.
Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.
Rephonic pulls ratings and reviews for Lung Cancer Update from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.
View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.
Rephonic provides full transcripts for episodes of Lung Cancer Update. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.
Recent guests on Lung Cancer Update include:
1. Dr. Jacob Sands
2. Ben Levy
3. Dr. Justin Gainor
4. Dr. Edward Garon
5. Dr. Sarah Goldberg
6. Dr. Josh Sabari
7. Stephen Liu
8. Jacob Sands
To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.